Menu

Image of the Day: Cold Hearted 

Cardiologists have found a way to cool the human heart in a localized way to help reduce muscle damage from heart attacks. 

Jan 22, 2018
The Scientist Staff, The Scientist Staff

Thermal image of a human heart, the cooled portion visible as a dark spot (bottom)CATHARINA HOSPITAL EINDHOVEN For the first time, doctors have demonstrated that it is possible to safely cool a portion of the human heart during a heart attack. In 10 human patients, they showed that cooling a specific portion of the heart—affected by a constricted artery—down to about 5 °C can limit damage to heart muscle after the artery is cleared. 

The Catharina Heart and Vascular Center is currently undertaking a follow-up study to assess the effectiveness and heath benefits of this procedure. 

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.